Stock listing
Rein Therapeutics, Inc.
Selected listing: 015A · TRADEGATE · EUR · DE
Rein Therapeutics, Inc. (Tradegate:015A), Health Technology. Latest release Sep 4, 2026: Rein Therapeutics to Present Late-Breaking Poster at the European…
- Ticker
- Tradegate:015A
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Tradegate
- Currency
- EUR
About Rein Therapeutics, Inc.
The company focuses on developing innovative therapeutic solutions. Investors can find detailed information about its operations and performance on its dedicated public company page.
Latest news from Rein Therapeutics, Inc.
Rein Therapeutics to Present Late-Breaking Poster at the European Respiratory Society (ERS) 2026 Congress
September 4, 2026
Rein Therapeutics to Present at Upcoming September Investor Conferences
September 3, 2026
Rein Therapeutics Receives U.S. FDA Fast Track Designation for LTI-03 in Idiopathic Pulmonary Fibrosis
August 20, 2026
Rein Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 14, 2026
Rein Therapeutics Announces Publication of Landmark LTI-03 Clinical Data in Nature Communications
August 4, 2026
Research Rein Therapeutics, Inc.
Rein Therapeutics, Inc. company profile
View the public company page for Rein Therapeutics, Inc. on 6ix.
Rein Therapeutics, Inc. news
Read company news and market updates connected to Rein Therapeutics, Inc..
Rein Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Rein Therapeutics, Inc..